Cookies
Cookies
What are cookies?
Cookies are small text files that are stored in your browser and are used by most websites, including this website, to help personalise your web experience. Some features on this website will not function if you do not allow cookies. You can learn more about cookies at: WhatAreCookies.com.
Guidance on how to tell your browser not to write cookies can be found at the following links.
Instructions for Internet Explorer 7 & 8
Instructions for Interner Explorer 9
Instructions for Firefox
Instructions for Safari
Instructions for Chrome
Google Analytics
We use Google Analytics to analyse how visitors use our site in aggregate form. Google Analytics uses cookies to identify unique visitors and record how they use a website. It does not collect any personally identifiable information and does not track movements between different websites.
You can “opt out” of Google Analytics cookies by installing the Google Analytics Opt-out Browser Add-on to block Google Analytics on all websites, or you can configure your browser to block cookies.
Please note that Imperial Consultants is not responsible for the content of these sites, nor can we be held responsible for any changes to your computer should you choose to make the changes described in these links.
Latest news, insights and events
Imperial’s COVID-19 vaccine explained
As the first trials of Imperial’s COVID-19 vaccine candidate got underway in June, Professor Robin Shattock, Dr Katrina Pollock and Dr David Owen explain how the vaccine works, how it’s being trialled, and plans to help it reach populations around the world, if it proves to be effective in protecting people against COVID-19. read more
The global energy revolution
Dr Iain Staffell, Dr Malte Jansen and consultants from e4Tech commissioned by Drax Group to inform the debate on decarbonising the global energy system, evaluating progress and lessons learnt re fossil fuels, clean power, electric vehicles, carbon capture and storage and efficiency read more
Imperial Consultants contribute to novel pain drug success
Australian pharmaceutical company, Spinifex Pharmaceuticals (“Spinifex”) has recently presented the clinical development of their lead product at the 14th World Congress of Pain®, highlighting the success of consultancy through Imperial Consultants. read more